Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non- steroidal anti-inflammatory drug NS-398

International Journal of Cancer

Volumn 86, Issue 4, 2000, Pages 553-560

  Elder, Douglas J E ^a   Halton, Dawn E ^a   Crew, Tracey E ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

APOPTOSIS; ARTICLE; CELL GROWTH; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034019416     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000515)86:4<553::aid-ijc18>3.0.co;2-9     Document Type: Article

References (23)

1. BARRY, O.P., KAZANIETZ, M.G., PRACTICO, D. and FITZGERALD, G.A., Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. biol. Chem., 274, 7545-7556 (1999).
2. CHAN, T.A., MORIN, P.J., VOGELSTEIN, B. and KINZLER, K.W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. nat. Acad. Sci. (Wash.), 95, 681-686 (1998).
3. 2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res., 59, 2739-2746 (1999).
4. ELDER, D.J.E., HAGUE, A., HICKS, D.J. and PARASKEVA, C., Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56, 2273-2276 (1996).
5. ELDER, D.J.E., HALTON, D.E., HAGUE, A. and PARASKEVA, C., Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res., 3, 1679-1683 (1997).
6. HANIF, R., PITTAS, A., FENG, Y., KOUTOS, M.I., QIAO, L., STAIANO-COICO, L., SHIFF, S.J. and RIGAS, B., Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245 (1996).
7. KAWAMORI, T., RAO, C.V., SEIBERT, K. and REDDY, B.S., Chemoprevention activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412 (1998).
8. LU, X., XIE, W., REED, D., BRADSHAW, W.S. and SIMMONS, D.L., Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. nat. Acad. Sci. (Wash.), 92, 7961-7965 (1995).
9. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809 (1996).
10. OTTO, J.C., DEWITT, D.L. and SMITH, W.L., N-Glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. biol. Chem., 24, 18234-18242 (1993).
11. PASRICHA, P.J., BEDI, A., O'CONNOR, K., RASHID, A., AKHTAR, A.J., ZAHURAK, M.L., PIANTADOSI, S., HAMILTON, S.R. and GIARDIELLO, F.M., The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109, 994-998 (1995).
12. PIAZZA, G.A. and 15 OTHERS, Sulindae sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57, 2909-2915 (1997a).
13. PIAZZA, G.A., RAHM, A.K., FINN, T.S., FRYER, B.H., LI, H., STOUMEN, A.L., PAMUKCU, R. and AHNEN, D.J., Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res., 57, 2452-2459 (1997b).
14. QIAO, L., KOZONI, V., TSIOULIAS, G.J., KOUTSOS, M.I., HANIF, R., SHIFF, S.J. and RIGAS, B., Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. biophys. Acta, 1258, 215-223 (1995).
15. 2 in human colon cancer cells. Cancer Res., 58, 362-366 (1998).
16. SHIFF, S.J., QIAO, L., TSAI, L., and RIGAS, B., Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. clin. Invest., 96, 491-503 (1995).
17. SHIFF, S.J., KOUTSOS, M.I., QIAO, L. and RIGAS, B., Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188 (1996).
18. SINGH, J., KULKARNI, N., KELLOFF, G. and REDDY, B.S., Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis, 15, 1317-1323 (1994).
19. SMITH, C.A., WILLIAMS, G.T., KINGSTON, R., JENKINSON, E.J. and OWEN, J.J.T., Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (Lond.), 337, 181-184 (1989).
20. SUBBARAMAIAH, K., CHUNG, W.J. and DANNENBERG, A.J., Ceramide regulates the transcription of cyclooxygenase-2. J. biol. Chem., 273, 32943-32949 (1998).
21. 2 in human prostatic carcinoma cells. Brit. J. Cancer, 75, 1111-1118 (1997).
22. WILLIAMS, C.S. and DUBOIS, R.N., Prostaglandin endoperoxide synthase: why two isoforms? Amer. J. Physiol., 270, G393-G400 (1996).
23. WILLIAMS, C.S., LUONGO, C., RADHIKA, A., ZHANG, T., LAMPS, L.W., NANNEY, L.B., BEAUCHAMP, R.D. and DUBOIS, R.N., Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111, 1134-1140 (1996).